Synthetic Biologics Inc. (SYN) was a big mover last session with its shares surging nearly 20% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has gained over 32% in the past one-month time frame.
This biotechnology company has seen no estimate revision in the last 60 days. However, the Zacks Consensus Estimate has moved higher over the same period. This implies solid trading ahead for the company. So make sure to keep an eye on this stock going forward to see if yesterday’s sharp climb can turn into more strength down the road.
Synthetic Biologics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Better-ranked stocks in the bio-medical industry include Gentium S.p.A (GENT), Retrophin, Inc. (RTRX) and Idenix Pharmaceuticals Inc. (IDIX). While Gentium sports a Zacks Rank #1 (Strong Buy), Retrophin and Idenix bear a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment